Pharmaceuticals

Merck KGaA Cut To Hold From Buy At Citi

By By Barbara Kollmeyer| MarketWatch Pulse| Markets

… By Barbara Kollmeyer MarketWatch Pulse MADRID -- German pharmaceutical and chemical company Merck KGaA was downgraded to hold from buy on Friday at Citigroup, which said the risk-reward looks evenly …

Story|11/20/2009

Merck Receives Recommendation for Fertility Drug

By By Darryl R. Isherwood| FOXBusiness| Markets

… Darryl R. Isherwood FOXBusiness A European advisory committee has recommended approval for Merck & Co.'s (MRK) new fertility drug Elonva. The Committee for Medicinal Products for Human Use of the European Medicines Agency made the recommendation, which …

Story|11/20/2009

Drug Stocks Cling To Flat Line; Poniard Falls

By By Val Brickates Kennedy| MarketWatch Pulse| Markets

… Val Brickates Kennedy MarketWatch Pulse BOSTON -- Drug stocks clung to the flat line early Friday as shares of Poniard Pharmaceuticals slid for the second day. The NYSE Arca Pharmaceutical Index was down marginally at 301.14 while the NYSE …

Story|11/20/2009

Market Winners & Losers: King Pharmaceuticals, MBIA

By By David O'Brien| FOXBusiness| Markets

… 3% and the Nasdaq slipping 1.7%. Here are Thursday’s winners and losers: Winners King Pharmaceuticals Inc. (KG) The pharmaceutical company saw its stock jump 5.1% to a yearly high. KG shares last traded at $11.76, a gain …

Story|11/19/2009

Allergan, Medicis Lead Drug Stocks Lower

By By Val Brickates Kennedy| MarketWatch Pulse| Markets

… MarketWatch Pulse BOSTON -- Allergan Inc. and Medicis Pharmaceutical Corp. led drug stocks lower early Thursday as shares of the ..... excise tax on cosmetic procedures. The NYSE Arca Pharmaceutical Index and the NYSE Arca Biotechnology Index were …

Story|11/19/2009

UK Health Unit Rejects Bayer Drug As Too Expensive

By By Robert Daniel| MarketWatch Pulse| Markets

… Reuters reported that the drug extends patients' life by ..... four months on average. The drug is produced by Bayer, the ..... in partnership with Onyx Pharmaceuticals , Emeryville, Calif. Bayer ..... treatment package, but the drug is still too expensive, the …

Story|11/19/2009

Sanofi-Aventis To Launch Antimalarial Drug Study

By By Sarah Turner| MarketWatch Pulse| Markets

… Turner MarketWatch Pulse LONDON -- French drugmaker Sanofi-Aaventis and Medicines for Malaria ..... and efficacy study of an antimalarial drug . A field-monitoring program on ASAQ ..... October. MMV is a not-for-profit drug research and development organization …

Story|11/19/2009

AstraZeneca Submits Brilinta NDA To FDA

By By Sarah Turner| MarketWatch Pulse| Markets

… By Sarah Turner MarketWatch Pulse LONDON -- Drugmaker AstraZeneca said Thursday that it has submitted a new drug application to the U.S. Food and Drug Administration for ticagrelor, an investigational oral antiplatelet …

Story|11/19/2009

Cavuto: Stick It to the Rich

By By Neil Cavuto, Managing Editor & Anchor| FOXBusiness| Markets

… Things like taxing insurers on high-value or so-called "Cadillac" plans. Or levying new taxes on insurance companies and drug companies...The fear there being those guys will only pass those increases along to customers. So customers balk...And …

Story|11/18/2009

Vivus Shares Rise on Erectile Dysfunction Drug Success

By By Darryl R. Isherwood| FOXBusiness| Markets

… Wednesday on news that its erectile dysfunction drug was effective in a late stage trial, putting ..... to file an application with the Food and Drug Administration in 2011. The shares were up about ..... current therapies.” The success of its ED drug comes as Vivus is planning to file a new …

Story|11/18/2009